J&J’s Longstreet: Medicare, Global Payment Reforms Move To Front Of Queue
This article was originally published in The Gray Sheet
Executive Summary
Medicare reforms for small manufacturers, MDUFMA implementation and the need to step up international lobbying efforts are 2003 priorities to be stressed by AdvaMed Chairman Dennis Longstreet at the trade group's annual meeting in Aventura, Fla. March 19-22
You may also be interested in...
Clinical Trial New Device Coverage Key For Small Firms, AbioMed Exec Says
A provision authorizing Medicare to cover routine costs of clinical trials for investigational devices likely will be attached to prescription drug legislation due after lawmakers return from the Memorial Day recess June 2
Clinical Trial New Device Coverage Key For Small Firms, AbioMed Exec Says
A provision authorizing Medicare to cover routine costs of clinical trials for investigational devices likely will be attached to prescription drug legislation due after lawmakers return from the Memorial Day recess June 2
AdvaMed Initiative Targets Small Firms; Mentor Program In Works
The addition of two small company chief executives to AdvaMed's board of directors demonstrates the mounting dependence of large device firms on smaller ones for technological innovation and perceived unity on Capitol Hill